New family of molecules to join altered receptors in neurodegenerative diseases
Imidazoline receptors I2: Looking for new therapeutic targets
Read morePHARMACEUTICAL CHEMISTRY
An antibiotic masquerading as a natural compound in the Giant Madeiran Squill
A previous study has shown that a type of squill growing in Madeira produces a chemical compound that may be
Read moreCAS releases open access dataset of antiviral chemical compounds to aid COVID-19 analysis
Columbus, OH, April 2, 2020 – CAS, a division of the American Chemical Society specializing in scientific information solutions, is
Read moreFatty acid in triglycerides proves an effective platform for biological drug delivery
HOUSTON-(April 1, 2020)-We’ve all been warned about the dangers of triglycerides, the fat stored in your blood. But what if
Read moreCancer research, the guardian of the genome has a new ally
A team of researchers of the University of Trento focused on a new molecular mechanism that works like a ‘switch’
Read moreResearchers gain new insights into pain signaling in the brain
Fast communication between our brain cells – or neurotransmission as it is called – is hugely important for our brain
Read moreCancer research, the guardian of the genome has a new ally
A team of researchers of the University of Trento focused on a new molecular mechanism that works like a ‘switch’
Read moreResearchers gain new insights into pain signaling in the brain
Fast communication between our brain cells – or neurotransmission as it is called – is hugely important for our brain
Read moreOral apixaban as good as dalteparin for treating cancer-associated clots
No increase in the risk of major bleeding seen, including for gastrointestinal cancers
Read moreRenal denervation effective in patients with untreated hypertension
No serious adverse effects seen after three months of follow-up
Read moreTicagrelor alone, without aspirin, shows benefit in patients with diabetes
No increase in bleeding, heart attack or stroke in TWILIGHT trial subanalysis
Read moreBenefit seen for ticagrelor alone, without aspirin, in patients with ACS
Finding driven by reduced risk of major bleeding in monotherapy group
Read more